"It could also be the case that the underlying indication, for example, which is obesity, is also known to have a higher risk for mental health issues," he says
This may, however, be due to the low dose of glutamine
Keep some on hand for the first few days after each dose increase
Recent updates Jul 23, 2026Retatrutide reported two more successful Phase 3 trials 20.8% weight loss in people with type 2 diabetes and 22.6% in people with severe obesity and heart disease and Lilly pushed its FDA submission to early 2027
The answer depends on several factors, including the cause and severity of deficiency, your overall health, and how long symptoms have been present
If you aim for maximum weight loss and tolerate dual-pathway activation well, tirzepatide's stronger metabolic effect may align with your goals